S100B is expressed and released by astro and oligodendrocytes in response to glial activation or injury and was recently studied as a potential serum biomarker for traumatic brain injury, stroke, depression, and blood brain barrier injury (Blyth et al. 2009; Schroeter et al. 2013; Vos et al. 2004). This evidence concerns the gene S100B and major depressive disorder.